Archean Chemical Industries Ltd Q1 FY2026 Concall Summary

Key Takeaways

• Revenue up 30%, but EBITDA lags: Revenue grew 30% YoY to ₹291.5 crore, while EBITDA rose only 13% to ₹95.8 crore as subsidiary ramp-up costs and higher freight weighed on margins.
• Bromine pricing inflection is underway: Prices moved past \$2.4/kg toward \$2.5/kg and above starting May/June; the full benefit will flow through this quarter and next as old, lower-priced orders roll off.
• Subsidiary losses are masking standalone strength: Consolidated PAT of ₹401 crore vs standalone PAT of ₹518 crore reflects initial losses at Acume Chemicals and Idealis Chemicals, both in their first year of full operation and still expensing raw materials ahead of production.
• Multiple new verticals are in trial phase: SOP plant trials, Idealis Mudchemie commercial production, potash scale-up, and semiconductor groundwork all sit in pre-revenue or early-revenue stages, making H2 FY26 the critical delivery window.
• What to watch next quarter: Whether bromine pricing gains actually convert to reported revenue, whether Idealis Chemicals starts commercial sales by Q3 as guided, and whether the monsoon buffer strategy prevents shipment disruption from Jakhau.

Bromine: Pricing Recovery & Volume Stability

• Pricing turned in May/June: After a period of softness, bromine prices moved past \$2.4/kg and are now closer to \$2.5/kg, with some deals higher. The Q1 P&L still reflects a mix of old and new orders, so the full uplift will only become visible as legacy contracts are extinguished.
• Long-term contracts provide volume floor: Bilateral relationships spanning 5-7 years with key customers support consistent demand and insulate volumes from spot price swings. Management stated the order book is full.
• Volume guidance was not confirmed: When an analyst asked whether contracts are in place to hit a 5,500-ton run rate next quarter, management declined to confirm the number, saying only that the order book is full.
• External elemental bromine sales declined YoY: External sales fell from 4,700 tons to 3,600 tons YoY. Management did not have the figure in front of them and committed to follow up.

Pendurthi: "So I think we've moved past that number. So we are closer to USD2.5 and a little bit more, in fact, on some cases."

Subsidiary Drag: The Consolidation Gap

• Standalone vs consolidated PAT gap is structural, not operational: The ₹117 crore difference between standalone PAT (₹518 crore) and consolidated PAT (₹401 crore) stems from initial losses at Acume Chemicals and Idealis Chemicals. Both are in their first year of full operation, where raw material purchases exceed production and get expensed immediately.
• Management expects normalization to close the gap: Once production scales and the raw-material pre-loading phase passes, subsidiary losses should shrink and consolidated performance should converge toward standalone. No timeline was given.
• Idealis Chemicals timeline is slipping: The ₹150 crore FY26 top-line target for Idealis Chemicals is maintained for now, but management left the door open to a revision, noting that ramp-up and technical approvals are taking more time than anticipated. Commercial production is now expected to start from Q3.

Pendurthi: "Well, I think if I were to look at it conservatively, I would possibly lower it. But I think is INR 150 crores realistic? I think we should aim for that."

New Verticals: Trial-Stage Pipeline

• SOP plant trials are imminent: Trial runs are progressing well, with work ongoing to improve conversion ratios. Plant trials are being prepared for the coming quarter, and management expects meaningful contributions from SOP in H2 FY26.
• Idealis Mudchemie (formerly Oren Hydrocarbon) is in customer qualification: Trial runs have commenced in two units, and product qualification is underway. Local offices of MNCs and certain Middle East customers have tested and approved products. The end markets are the Middle East.
• Potash scale-up is in progress: Pilot trials were successful, equipment has been ordered, and raw material is in place. Meaningful contribution is expected this year, with improvements anticipated over the next few quarters.
• Semiconductor project begins post-monsoon: Land acquisition in Odisha is complete, RFQs have been tendered for a project management office, and groundwork will commence after the monsoon.
• Flame retardant details were withheld: When asked whether Archean's planned portfolio overlaps with toxic flame retardants facing bans, management declined to answer, stating they will return with details once the plan is finalized.

Bromine Derivatives: Early-Stage Ramp

• Capacity utilization is at 30-40%: The bromine derivatives plant is running well below potential, with clear brine fluids and PTA catalysts contributing to Q1 revenue of ₹23 crore. Management expects utilization to gradually improve to over 50% before FY26 ends.
• Product pipeline is broadening: Two to three additional products will be introduced in the bromine derivatives space over the next couple of quarters. As utilization rises, sales are expected to move up through the rest of the year.
• Demand is not the bottleneck: Management stated that good demand continues despite global challenges and tariff uncertainty, and that the only job is to make the product, not to find buyers.

Salt & Logistics: Volume Steady, Costs Elevated

• Industrial salt volumes held at 0.11 crore tons: Earlier logistical challenges have been largely resolved through the addition of owned, leased, and third-party equipment. Management expects to maintain the current run rate and work toward increasing volumes.
• Pricing weakness was offset by efficiency: Salt prices softened over the last six months as the global petrochemical and chlor-alkali business faced headwinds, but efficiency improvements compensated.
• EBITDA growth lagged salt revenue growth for a different reason: The modest ₹7 crore YoY EBITDA increase against an ₹80 crore YoY salt revenue jump is driven by downstream derivative subsidiary ramp-up costs at Acume, not by salt pricing pressure.
• Monsoon buffer is in place: To mitigate the risk of shipment delays from the Jakhau facility during August-September rains, the company purchased extra material as a buffer covering at least two shipments.

Pendurthi: "So what we have done to mitigate that risk, because we always run at 100% on salt exports and logistics, we have purchased some extra material as a buffer and that will allow us to kick start the season immediately without having to wait post monsoon from Jakhau."

Guidance & Commitments

Key Metrics